CPhI Worldwide

Short-Term Reshoring

The second part of the 2021 CPhI Annual Report looks ahead to predict the pharma manufacturing, therapeutic and technology environment in 2030.

Topics • Strategy

CPhI Worldwide Returns to Madrid

Top-Feature

Aenova Holding GmbH

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Impress PR

Informa Markets

CPhI Worldwide

Short-Term Reshoring

Patient Centricity: The New Nexus for CDMOs

CPhI Worldwide Announces International Advisory Board

CPhI Announces Founding Members of Expert Industry Panel

CPhI, PharmaEvolution to Analyze Pharma Industry in Monthly and Annual Reports